Rural Cancer Survival Rates Lower Than Urban Populations
Okay,here’s a breakdown of the key details from the provided text,focusing on cancer survival disparities based on race (Black vs. White) and location (metropolitan vs. non-metropolitan areas):
Overall Findings:
* Lower Survival in Non-Metropolitan Areas: A study by the American Cancer Society (ACS) found that 5-year cancer survival rates were lower for both Black and White patients in non-metropolitan areas compared to their metropolitan counterparts.
* Disparities Exist Within Both Groups: disparities in survival rates were observed both overall and when looking specifically at Black and White patients, and further broken down by location (urbanicity).
* Root Cause: The study suggests these disparities are largely due to inequities in access to quality cancer care, linked to social determinants of health (like lack of insurance).
Specific Survival Rate Differences (Key Numbers):
* Overall Survival (OS) by Stage:
* Localized: 2% lower in non-metro areas.
* Regional: 5% lower in non-metro areas.
* Distant: 3-7% lower in non-metro areas.
* Lung Cancer (Localized Stage): The largest difference was observed here.
* Black patients in non-metro areas: ~12% lower OS.
* White patients in non-metro areas: ~10% lower OS.
* Regional-Stage Cancers (Large Metropolitan Areas):
* Black patients: 7% lower OS (61.8% vs 68.5% for White patients).
* Distant-Stage Cancers (Large Metropolitan Areas):
* Black patients: 7% lower OS (32.9% vs 39.8% for White patients).
* Distant-Stage Cancers (Small-Medium Metropolitan Areas):
* Black patients: 5% lower OS (31.3% vs 36.1% for White patients).
* Distant-Stage Cancers (non-Metropolitan areas):
* Black patients: 4% lower OS (29.5% vs 33.3% for White patients).
* Localized Prostate Cancer (metropolitan Areas):
* Black patients: ~1% lower OS.
* Distant Prostate Cancer (Large Metropolitan Areas):
* Black patients: ~4% lower OS.
* Localized Lung Cancer (Large Metropolitan Areas):
* Black patients: 6% lower OS.
* Non-Metropolitan Areas: 9% lower OS.
* Regional Lung Cancer (Large Metropolitan Areas):
* Black patients: 4% lower OS.
Key Takeaway:
The study highlights a meaningful and concerning disparity in cancer survival rates based on both race and geographic location. Access to quality care, influenced by social determinants of health, appears to be a major contributing factor.
Let me know if you’d like me to elaborate on any specific aspect of this information!